Guaranteeing Access to Medicines: Reforming Trade and Investment Treaties in the COVID-19 Era

Eight months into COVID-19, what is the status of the international investment regime and access to essential medicines? The GDP Center’s Working Group on Trade and Access to Medicines will host a panel discussion on trade, investment regime, and access to essential medicines. The event is co-sponsored by the South Centre, the intergovernmental organization of developing nations based in Switzerland.


  • Kevin P. Gallagher – Director, Global Development Policy Center; Professor, Pardee School of Global Studies Boston University


  • Carlos Correa – Executive Director, South Centre
  • Mustaqeem de Gama – Counsellor, South Africa WTO Mission
  • Dr. Martin Howell Friede – Unit Lead, Vaccine Research, Department of Immunization, Vaccines and Biologics, World Health Organization
  • Yousuf Vawda –  Professor & Senior Research Associate, University of Kwazulu-Natal School of Law
  • Deborah Gleeson – Senior Lecturer, La Trobe University
7:00 am EST//1:00 pm CET on Friday, Dec. 11, 2020
08:30 am EST//2:30 pm CET on Friday, Dec. 11, 2020
Via Zoom